Literature DB >> 18252904

Translating the Diabetes Prevention Program into an urban medically underserved community: a nonrandomized prospective intervention study.

Miriam C Seidel1, Robert O Powell, Janice C Zgibor, Linda M Siminerio, Gretchen A Piatt.   

Abstract

OBJECTIVE: The objective of this study was to determine if a community-based modified Diabetes Prevention Program Group Lifestyle Balance (GLB) intervention, for individuals with metabolic syndrome, was effective in decreasing risk for type 2 diabetes and cardiovascular disease (CVD) in an urban medically underserved community, and subsequently to determine if improvements in clinical outcomes could be sustained in the short term. RESEARCH DESIGN AND METHODS: This nonrandomized prospective intervention study used a one-group design to test the effectiveness of a community-based GLB intervention. Residents from 11 targeted neighborhoods were screened for metabolic syndrome (n = 573) and took part in a 12-week GLB intervention (n = 88) that addressed safe weight loss and physical activity.
RESULTS: A marked decline in weight (46.4% lost > or = 5% and 26.1% lost or = 7%) was observed in individuals after completion of the intervention. Of these subjects, 87.5% (n = 28) and 66.7% (n = 12) sustained the 5% and 7% reduction, respectively, at the 6-month reassessment. Over one-third of the population (43.5%, n = 30) experienced improvements in one or more component of metabolic syndrome, and 73.3% (n = 22) sustained this improvement at the 6-month reassessment. Additional improvements occurred in waist circumference (P < 0.009) and blood pressure levels (P = 0.04) after adjustment for age, sex, race, mean number of GLB classes attended, and time.
CONCLUSIONS: Adults in an urban medically underserved community can decrease their risk for type 2 diabetes and CVD through participation in a GLB intervention, and short-term sustainability is feasible. Future research will include long-term follow-up of these subjects.

Entities:  

Mesh:

Year:  2008        PMID: 18252904     DOI: 10.2337/dc07-1869

Source DB:  PubMed          Journal:  Diabetes Care        ISSN: 0149-5992            Impact factor:   19.112


  67 in total

1.  Potential national and state medical care savings from primary disease prevention.

Authors:  Barbara A Ormond; Brenda C Spillman; Timothy A Waidmann; Kyle J Caswell; Bogdan Tereshchenko
Journal:  Am J Public Health       Date:  2010-11-18       Impact factor: 9.308

Review 2.  A systematic review of the translational research on the Diabetes Prevention Program.

Authors:  Robin Whittemore
Journal:  Transl Behav Med       Date:  2011-09       Impact factor: 3.046

3.  Design of a randomized trial of diabetes genetic risk testing to motivate behavior change: the Genetic Counseling/lifestyle Change (GC/LC) Study for Diabetes Prevention.

Authors:  Richard W Grant; James B Meigs; Jose C Florez; Elyse R Park; Robert C Green; Jessica L Waxler; Linda M Delahanty; Kelsey E O'Brien
Journal:  Clin Trials       Date:  2011-10       Impact factor: 2.486

4.  Design and methods of "diaBEAT-it!": a hybrid preference/randomized control trial design using the RE-AIM framework.

Authors:  Fabio A Almeida; Kimberlee A Pardo; Richard W Seidel; Brenda M Davy; Wen You; Sarah S Wall; Erin Smith; Mark H Greenawald; Paul A Estabrooks
Journal:  Contemp Clin Trials       Date:  2014-06-21       Impact factor: 2.226

5.  The Healthy Living Partnerships to Prevent Diabetes study: 2-year outcomes of a randomized controlled trial.

Authors:  Jeffrey A Katula; Mara Z Vitolins; Timothy M Morgan; Michael S Lawlor; Caroline S Blackwell; Scott P Isom; Carolyn F Pedley; David C Goff
Journal:  Am J Prev Med       Date:  2013-04       Impact factor: 5.043

6.  Translating an evidence-based lifestyle intervention program into primary care: lessons learned.

Authors:  Andrea C Blonstein; Veronica Yank; Randall S Stafford; Sandra R Wilson; Lisa Goldman Rosas; Jun Ma
Journal:  Health Promot Pract       Date:  2013-03-28

7.  A 3-year randomized trial of lifestyle intervention for cardiovascular risk reduction in the primary care setting: the Swedish Björknäs study.

Authors:  Margareta K Eriksson; Paul W Franks; Mats Eliasson
Journal:  PLoS One       Date:  2009-04-14       Impact factor: 3.240

8.  Evaluation of lifestyle interventions to treat elevated cardiometabolic risk in primary care (E-LITE): a randomized controlled trial.

Authors:  Jun Ma; Abby C King; Sandra R Wilson; Lan Xiao; Randall S Stafford
Journal:  BMC Fam Pract       Date:  2009-11-12       Impact factor: 2.497

9.  Cost-effectiveness analysis of efforts to reduce risk of type 2 diabetes and cardiovascular disease in southwestern Pennsylvania, 2005-2007.

Authors:  Kenneth J Smith; Heather E Hsu; Mark S Roberts; M Kaye Kramer; Trevor J Orchard; Gretchen A Piatt; Miriam C Seidel; Janice C Zgibor; Cindy L Bryce
Journal:  Prev Chronic Dis       Date:  2010-08-15       Impact factor: 2.830

10.  Associations of cardiovascular risk factors in Al Ain, United Arab Emirates.

Authors:  Latifa M Baynouna; Anthony D Revel; Nico J D Nagelkerke; Tariq M Jaber; Aziza O Omar; Nader M Ahmed; Mohammad K Nazirudeen; Mamdouh F Al Sayed; Fuad A Nour; Sameh Abdouni
Journal:  Cardiovasc Diabetol       Date:  2009-04-16       Impact factor: 9.951

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.